Asia & Africa Polyethylene Wax Market Get Facts About Business Strategies 2018 to 2025: Grand View Research Inc.

 The Asia & Africa polyethylene wax market size is expected to reach USD 595.1 million by 2025, according to a new report by Grand View Research, Inc. Polyethylene (PE) wax is used globally in diversified industries including coating, printing ink, adhesives, food packaging, and masterbatches. 

Ethylene emerges as a key raw material used in the manufacture of polyethylene. Unstable crude oil prices and geopolitical issues are affecting raw material trends. The industry will be driven by high supply from Asia Pacific countries including India, China, and Japan coupled with technological innovations.

HDPPE and LDPPE waxes are obtained using polymerization technology. Oxidized, modified, acid-modified are manufactured using modification technology. Low density cracked is produced by thermal cracking of LDPPE wax.

China consists of a large number of PE manufacturers with flexible prices. Also, government initiatives to develop shale gas reserves by 2020 are also expected to contribute positively towards low cost and high level of ethylene production. The Middle East, on account of well-established oil & gas infrastructure, is also projected to make a significant contribution towards industry growth.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/asia-africa-polyethylene-pe-wax-market

Further key findings from the report suggest:

• The Asia PE wax demand was USD 228.9 million in 2016 and is expected to grow at a CAGR of 10.2% from 2017 to 2025
• Growth of printing inks, adhesives, cosmetics, and pharmaceuticals particularly in emerging countries of the Asia Pacific and Africa are expected to have a positive impact on growth
• High polyethylene supplies from India and China coupled with rapid industrialization have resulted in high demand in the region
• Africa is also projected to observe a significant gain in its market size on account of oil & gas infrastructure development coupled with lower product prices
• The high density polymerized segment accounted for 40.5% of the volume in 2016 and is expected to grow at a high CAGR from 2017 to 2025
• High density polymerized PE wax is widely used as a lubricant for plastics processing and in the textile industry.
• Petrochemical manufacturers in the Asia Pacific have invested in large-scale ethylene plants, and have upgraded and expanded their facilities to cater to large demand arising in the region
• Mitsui Chemicals, Inc., Nanjing Tianshi New Material Technologies Co., Ltd., EPChem International Pte Ltd., Sanyo Chemical Industries, Ltd., and SCG Chemicals Co., Ltd. are the prominent leaders in the Asia & Africa polyethylene wax market.

Access Press Release@ https://www.grandviewresearch.com/press-release/asia-africa-polyethylene-pe-wax-market-analysis

Grand View Research has segmented the Asia & Africa polyethylene wax market on the basis of technology, product, application, and region:

Polyethylene Wax Technology Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Polymerization
• Modification
• Thermal Cracking

Polyethylene Wax Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• High-Density Polymerized PE Wax
• Low-Density Polymerized PE Wax
• Oxidized PE Wax
• Acid-Modified PE Wax
• Low-Density Cracked PE Wax
• Others

Polyethylene Wax Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Printing Inks
• Adhesives
• Masterbatches
• Plastics
• Rubber
• Others

Polyethylene Wax Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Asia
  • Australia
  • New Zealand
  • Malaysia
  • Indonesia
  • Thailand
• Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Molecular Diagnostics Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 

Molecular Diagnostics Market Growth & Trends

The global molecular diagnostics market size is expected to reach USD 17.97 billion by 2030, and expanding at a CAGR of 4.5% from 2024 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

Request a free sample copy or view report summary: Molecular Diagnostics Market Report

Molecular Diagnostics Market Report Highlights

• The reagents segment dominated the market and accounted for a share of 62.2% of the global revenue in 2023. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.
• The polymerase chain reaction technology segment accounted for the largest revenue share in 2023. This is attributed to its use in detecting COVID-19 and other infectious diseases.
• The infectious diseases segment accounted for the largest revenue share in 2023. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.
• The central laboratories segment dominated the industry in 2023 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.
• North America dominated the market and accounted for a 39.3% share in 2023. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.
• Asia Pacific is anticipated to exhibit significant growth from 2024 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-molecular-diagnostics-market

Molecular Diagnostics Market Segmentation

Grand View Research has segmented the global molecular diagnostics market report based on product, technology, application, test location, and region:

Molecular Diagnostics Product Outlook (Revenue, USD Million, 2018 – 2030)

• Instruments
• Reagents
• Others

Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018 – 2030)

• Polymerase chain reaction (PCR)
  • By Type
    • Multiplex PCR
    • Other PCR
  • By Product
    • Instruments
    • Reagents
    • Others
  • In Situ Hybridization (ISH)
    • Instruments
    • Reagents
    • Others
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Instruments
    • Reagents
    • Others
  • Chips and Microarrays
    • Instruments
    • Reagents
    • Others
  • Mass Spectrometry
    • Instruments
    • Reagents
    • Others
  • Sequencing
    • Instruments
    • Reagents
    • Others
  • Transcription Mediated Amplification (TMA)
    • Instruments
    • Reagents
    • Others
  • Others
    • Instruments
    • Reagents
    • Others

Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018 – 2030)

• Oncology
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Liver Cancer
  • Blood Cancer
  • Lung Cancer
  • Other Cancer
• Pharmacogenomics
• Infectious Diseases
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Clostridium Difficile
  • Vancomycin-resistant Enterococci (VRE)
  • Carbapenem-resistant Bacteria
  • Flu
  • Respiratory Syncytial Virus (RSV)
  • Candida
  • Tuberculosis and Drug-resistant TBA
  • Meningitis
  • Gastrointestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Other Infectious Diseases
• Genetic Testing
  • Newborn Screening
  • Predictive and Presymptomatic Testing
  • Other Genetic Testing
• Neurological Disease
• Cardiovascular Disease
• Microbiology
• Others

Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018 – 2030)

• Point of Care
• Self-test or OTC
• Central Laboratories

Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Belgium
  • Switzerland
  • The Netherlands
  • Poland
  • Austria
  • Turkey
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • New Zealand
  • Sri Lanka
  • Malaysia
  • Vietnam
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait
  • Jordan
  • Qatar
  • Egypt

List of Key Players of Molecular Diagnostics Market

• BD
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Abbott
• Agilent Technologies, Inc.
• Danaher
• Hologic Inc. (Gen Probe)
• Illumina, Inc.
• Grifols, S.A.
• QIAGEN
• Hoffmann-La Roche, Ltd.
• Siemens Healthineers AG
• Sysmex Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Saffron Market to Witness a Pronounce Growth During 2024 – 2030: Grand View Research Inc.

 

Saffron Market Growth & Trends

The global saffron market size is anticipated to reach USD 959.38 million by 2030, growing at a CAGR of 7.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to experience significant growth in the forecast period due to increasing demand for the spice in medical and cosmetic applications. Saffron is a potent source of antioxidants that provide numerous health benefits, with active compounds such as picrocrocin, safranal, and crocin contributing to reducing oxidative damage and inflammation in the brain. Its antioxidant, anti-inflammatory, and memory-enhancing properties are likely to drive market growth. In addition, the cosmetics industry uses saffron as a natural UV-absorbing agent.

Image processing technology, pilot scale, and electric nose are some of the key technologies used in processing saffron. Manual separation of stigmas has been the norm, but the image processing method offers a less time-consuming approach. ISO Standard 3632 is the requirement that governs quality measurement. However, adulteration is a growing concern in the global market due to saffron's high price and increased demand, with products resembling saffron being mixed in as adulterants.

The market in Middle East and Africa is growing and is attributable to the increasing demand to its use in traditional cuisine. Saffron is an essential ingredient in many dishes in the region, such as biryanis, pilafs, and tagines, and it is also used to flavor sweets and desserts. The spice is considered to be a symbol of hospitality and is often served to guests as a sign of respect.

In September 2022, Iran signed a USD 300 million deal with Qatar to supply saffron. Qatar received 200 tons of Iranian saffron, with the first shipment arrived on October 1st. The two countries have been expanding their economic and political ties, with trade exchange growing by 34% in 2021. The Qatari minister hopes to continue expanding economic, trade, and investment cooperation.

Request a free sample copy or view report summary: Saffron Market Report

Saffron Market Report Highlights

• Grade-I dominated the grade segment with highest revenue share in 2023. This is owing to the excellent coloring and flavoring strengths and aroma of this grade
• The traditional type accounted for a revenue share of 63.6% in 2023. The market for traditional saffron harvest is driven by several factors, including its unique flavor, aroma, and color, which make it a highly valued ingredient in cooking, cosmetics, and traditional medicine
• The market for liquid form is expected to witness a significant growth with a revenue CAGR of 7.9% over the projected period. The various uses of liquid form of saffron like its culinary and medicinal uses, saffron liquid is also used in the perfume industry to add a unique and exotic aroma to fragrances, is driving the segment
• The market for B2C distribution channel is expected to witness a significant growth with a revenue CAGR of 7.4% over the projected period owing to the rising prevalence of saffron products in online retail platforms and the increasing demand for saffron-based supplements and dietary items
• Middle East and Africa accounted for a revenue share of nearly 51.2% in 2023 owing to rising product demand in the personal care & cosmetic sector in the region owing to increasing recognition of saffron's health advantages, along with the surge in demand for organic and natural commodities

Access Press Release@ https://www.grandviewresearch.com/press-release/global-saffron-market

Saffron Market Segmentation

Grand View Research has segmented the global saffron market based on grade type, form, application, distribution and region:

Saffron Grade Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• Grade I
• Grade II
• Grade III
• Grade IV

Saffron Type Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• Organic
• Traditional

Saffron Form Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• Liquid
• Powder
• Stigma
• Petals
• Stamen

Saffron Application Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• Food supplements
• Cosmetics
• Personal care products
• Food & beverage
• Others

Saffron Distribution Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• B2B
• B2C

Saffron Regional Outlook (Volume, Tons; Revenue, USD Million; 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Iran

List of Key Players in the Saffron Market

• Esfedan Trading Company
• Safran Global Company S.L.U.
• Tarvand Saffron Co.
• Saffron Business Company
• Gohar Saffron
• Rowhani Saffron Co.
• Mehr Saffron
• Flora Saffron
• Royal Saffron Company
• Iran Saffron company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Grow Light Market Growth in the Coming Years

 Grow Light Market Growth & Trends

The global grow light market size is anticipated to reach USD 14.31 billion by 2030, growing at a CAGR of 15.0%, according to a new report by Grand View Research, Inc. The increased use of vertical farming and indoor cultivation, for producing crops, is likely to spur the market demand over the forecast period. Grow light helps in extending the hours of the natural daylight which further increases the health, growth rate, and yield of the plants. Artificial lighting, such as high-pressure sodium lighting, LED lighting and plasma lighting can extend the availability of crops throughout the season.

According to the UN, by 2050, around 80 percent of the world's population will live in cities. People continuously move into cities to get access to training, service, jobs, culture and entertainment, and all the other things cities offer. This means that the demand for food is increasing in these areas at the same time as the availability of arable land around cities is very limited.

Artificial lighting helps in extending the hours of the natural daylight which further increases the health, growth rate, and yield of the plants. Artificial lighting, such as high-pressure sodium lighting, LED lighting can extend the availability of crops (throughout a season). LED lighting systems produce dual-band color spectrum and generate low heat. They are anticipated to witness significant growth over the forecast period.

The U.S. government has increasingly started to legitimize cannabis plantations across various states. With this initiative, cannabis cultivation is on the verge to become a big business in some parts of the country. Cannabis growers prefer Controlled-Environment Agriculture (CEA) to enhance product quality and yield. This setup consumes a high amount of electricity. As government officials and power companies are trying to convert this into a green industry, they are encouraging the use of LEDs to reduce power consumption and greenhouse gas emissions.

Request a free sample copy or view report summary: Grow Light Market Report

Grow Light Market Report Highlights

• The escalating urban population and lack of arable land around cities is expected to drive the market
• The plasma technology segment is expected to portray high growth rate with a CAGR of 21.9% over the projected period
• New installations and replacement lights, increasing urban cultivation, increasing vertical farming and government initiatives are expected to be the drivers of the market over the forecast period
• The Asia Pacific regional market is expected to have significant growth over the forecast period, owing to the technological advancement and commercial vertical farms

Access Press Release@ https://www.grandviewresearch.com/press-release/global-grow-light-market

Grow Light Market Segmentation

Grand View Research has segmented the global grow light market based on application, product, system, technology, installation, spectrum, and region:

Grow Light Application Outlook (Revenue, USD Million, 2017 - 2030)

• Indoor Farming
• Vertical Farming
• Commercial Greenhouse
• Others

Grow Light Product Outlook (Revenue, USD Million, 2017 - 2030)

• < 300 Watt
• > 300 Watt

Grow Light System Outlook (Revenue, USD Million, 2017 - 2030)

• Hardware
• Software

Grow Light Technology Outlook (Revenue, USD Million, 2017 - 2030)

• High Intensity Discharge (HID)
• LED
• Fluorescent
• Plasma

Grow Light Installation Outlook (Revenue, USD Million, 2017 - 2030)

• New Installation
• Retrofit

Grow Light Spectrum Outlook (Revenue, USD Million, 2017 - 2030)

• Partial Spectrum
• Full Spectrum

Grow Light Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players of Grow Light Market

• AeroFarms
• EVERLIGHT ELECTRONICS CO., LTD.,
• GAVITA Holland bv
• Heliospectra AB
• Hortilux Schréder
• Illumitex
• LumiGrow Inc
• Osram Licht AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Polylysine Market Trends Regulations And Competitive Landscape Outlook to 2030

 Polylysine Market Growth & Trends

The global polylysine market is expected to reach USD 1.4 billion by 2030, registering CAGR of 7.6% during the forecast period, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising demand from several end-use applications such as cosmetics, food & beverage, pharmaceutical, and dietary supplements among others. The rising living standards and increasing consumer willingness to spend more on personal well-being are the factors expected to positively impact the market growth during the coming years.

Food & beverage emerged as a dominant application on account of the growing utilization of the product in numerous food items including cooked vegetables, boiled rice, noodles, soups, and sushi among others. This is attributable to the presence of antimicrobial and antioxidant properties in polylysine. It helps in reducing the chloride content, has excellent heat and water solubility, and does not have any unpleasant odor to it.

Asia Pacific region dominated the market on account of strong presence of the manufacturers in key countries including China, and Japan. Easy availability of raw materials and advanced technology has influenced the increased production across the region. Furthermore, the rising demand for the organic products from end-use industries such as cosmetics, food & beverages, and pharmaceuticals has triggered the market demand across the globe.

The polylysine market is consolidated with few manufacturers accounting for a majority of the market share. Few of the companies have a highly integrated supply chain that enables them to reach a broader customer base. They help in establishing a well-connected network the distributors with extensive regional presence and goodwill to easily cater to niche markets.

Request a free sample copy or view report summary: Polylysine Market Report

Polylysine Market Report Highlights

• Polylysine is used as an effective food preservative to increase shelf-life of the packaged food items. Factors such as increasing disposable income of the consumers, rapid urbanization, and availability of the ready-to-eat food products have led to increase in demand for the packaged foods, frozen foods, and desserts. This is expected to boost demand for the food preservatives, in turn, driving the market growth
• Pharmaceutical application is the fastest growing segment with a CAGR of 7.9% owing to the growing utilization of polylysine as a drug carrier in the formulation of the medicines
• Europe is the fastest growing region with a CAGR of 8.1% because of the strong presence of multinational companies engaged in polylysine production. Handary S.A., Siveele B.V., and Biobyt Ltd. are some of the major manufacturers of polylysine in the region
• The global manufacturers of the polylysine, such as JNC Corporation, Siveele B.V., Bimal Pharma Pvt. Ltd., and Handary S.A., are producing polylysine by means of the biotechnology and other advanced production techniques. These players are investing heavily in R&D activities to discover other alternate means of the polylysine production that can ensure higher yield while keeping the production cost under control
• The competitors in the market try to gain a reasonable advantage over others by means of expanding their global presence, price control, and strengthening product portfolios. These companies in order to strengthen their global presence, typically establish different types of contracts such as partnerships and joint ventures. For instance, Sino Lion USA has signed partnerships and joint ventures with multiple manufacturers from China and operates independently or jointly with Chinese partner companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-polylysine-market

Polylysine Market Segmentation

Grand View Research has segmented the global polylysine market report based on the application and region:

Polylysine Application Outlook (Revenue, USD Million; Volume, Tons; 2018 - 2030)

• Food & Beverages
• Pharmaceutical
• Personal Care & Cosmetics
• Dietary Supplements
• Others

Polylysine Regional Outlook (Revenue, USD Million; Volume, Tons; 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of the Key players in the global Polylysine Market include

• Chisso Co.
• Okuna Chemical Industries Co.
• SunBio Co.
• JNC Corporation
• Nanjing Shineking Biotech
• Chengdu Jinkai Biology
• Zhengzhou Bainafo Bioengineering
• Yiming Biological
• Siveele
• Lion King Biotechnology

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Clinical Trials Site Management Organizations Market Trends And Forecast 2024-2030: Grand View Research Inc.

 Clinical Trials Site Management Organizations Market Growth & Trends

The global clinical trials site management organizations market size is expected to reach USD 9.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.17% from 2024 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market.

Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time.

Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021.

Request a free sample copy or view report summary: Clinical Trials Site Management Organizations Market Report

Clinical Trials Site Management Organizations Market Report Highlights

• The project management segment dominated the market with a revenue share of 25.0% in 2023, due to the fact that it is required to ensure that clinical trials are set up, enrolled, reported on time, and conducted within the budget
• The phase III segment accounted for the largest revenue share of 54.16% in 2023. This growth is attributed to the fact that phase III trials are often the largest and involve thousands of participants and are the most expensive ones
• Based on therapeutic area, the oncology segment is anticipated to witness the fastest CAGR of 6.66% in the market during the forecast period, due to the high global prevalence of cancer, which is generating demand for drugs and thus increasing its market share
• Asia Pacific led the market in 2023 and is projected to witness the fastest CAGR of 6.87% during the forecast years, as cost-effective strategic solutions provided by SMOs could reduce timelines, as in changing market for clinical trials, fast recruitment, and a huge pool of patients are some of the prerequisites

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trials-site-management-organizations-smo-market

Clinical Trials Site Management Organizations Market Segmentation

Grand View Research has segmented the global clinical trials site management organizations market on the basis of clinical trial services/components, phase, therapeutic areas, and region:

Clinical Trials Site Management Organizations Clinical Trial Services/Component Outlook (Revenue, USD Million, 2018 - 2030)

• Site Management
• Project Management
• Regulatory
• Onsite Monitoring
• Others

Clinical Trials Site Management Organizations Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Site Management Organizations Therapeutic Areas Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Cardiology
• CNS
• Pain Management
• Endocrine
• Others

Clinical Trials Site Management Organizations Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players in the Clinical Trial Site Management Organizations Market

• Clinedge
• WCG
• ClinChoice
• Access Clinical Research
• FOMAT Medical Research INC.
• SGS
• KV Clinical
• SMO-Pharmina
• Xylem Clinical Research
• Aurum Clinical Research

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Structural Health Monitoring Market Latest Innovations, Drivers and Industry Key Events 2023– 2030: Grand View Research Inc.

 Structural Health Monitoring Market Growth & Trends

The global structural health monitoring market size is estimated to reach USD 10.48 billion by 2030, according to a study conducted by Grand View Research, Inc., rising at a CAGR of 18.8% from 2023 to 2030. Growing investments in infrastructural development and government regulations mandating implementation of sensors and data acquisition systems to monitor structure health are expected to augment the market. Increasing age of existing bridges and dams and rising focus on infrastructural advancements including construction of new bridges, dams, buildings, and stadiums are also providing a push to the market.

Superior infrastructure is essential for regional development and it helps to increase productivity of the private as well as public sectors. Therefore, rapid infrastructural development across the globe is one of the primary growth stimulants for the market. These systems help in reducing cost by removing need for inspection staff and maintenance. Additionally, with ongoing advancements in technology, these systems are being used in applications such as diagnosing vessels and platforms in marine industries, aircraft frames in aerospace and defense, and inspection of large machines.

North America is projected to dominate the market throughout the forecast horizon owing to surging demand from applications such as bridges & dams and buildings & stadiums. However, Asia Pacific is poised to post the highest CAGR of 18.9% during the same period. This is owing to increasing investments in the civil infrastructure sector, along with industries such as aerospace, defense, marine, and manufacturing. Moreover, in 2014, the Chinese government laid down new regulations mandating use of SHM systems while building new architectural structures and bridges. They have restricted replacement time period for an embedded sensor to 20 years and three to five years for a sensor placed on the surface of the bridge. Furthermore, expanding production of oil sands and shale gas in regions such as Africa and Asia are anticipated to stir up the demand for structural health monitoring systems.

Request a free sample copy or view report summary: Structural Health Monitoring Market Report

Structural Health Monitoring Market Report Highlights

• The hardware segment is likely to dominate the structural health monitoring market throughout the forecast period owing to higher cost of sensors and data acquisition systems as compared to that of software and services
• In terms of application, the market for structural health monitoring is dominated by bridges & dams and the trend is estimated to continue until 2030. This is due to increasing investments in order to check for health of structures, thus ensuring public safety
• Prominent industry participants include National Instruments Corporation; Structural Monitoring Systems; Digitexx Data Systems, Inc.; and Pure Technologies.
• North America dominated the global structural health market, accounting for the highest revenue share of 35.1% in 2022.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-structural-health-monitoring-shm-market

Structural Health Monitoring Market Segmentation

Grand View Research has segmented the global structural health monitoring market based on solution, application, technology, and region:

Structural Health Monitoring Solution Outlook (Revenue in USD Million, 2017 - 2030)

• Hardware
  • Sensors
  • Data Acquisition Systems
  • Others
• Software & Services

Structural Health Monitoring Technology Outlook (Revenue in USD Million, 2017 - 2030)

• Wired SHM
• Wireless SHM

Structural Health Monitoring Application Outlook (Revenue in USD Million, 2017 - 2030)

• Bridges & Dams
• Buildings & Stadiums
• Vessels & Platforms
• Airframes & Wind Turbines
• Large Machines & Equipments

Structural Health Monitoring Regional Outlook (Revenue in USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • United Arab Emirates (UAE)
  • Saudi Arabia
  • South Africa

List of Key Players of Structural Health Monitoring Market

• Acellent Technologies, Inc.
• Campbell Scientific, Inc.
• COWI A/S
• DIGI-TEXX
• Geocomp, Inc.
• GEOKON
• GeoSIG Ltd
• HBK
• James Fisher and Sons plc.
• Kinemetrics
• NATIONAL INSTRUMENTS CORP.
• Nova Ventures Group
• Sixense
• STRUCTURAL MONITORING SYSTEMS PLC
• Xylem

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ultra High Purity Silicon Carbide Market Set to Record Exponential Growth by 2027: Grand View Research Inc.

 Ultra High Purity Silicon Carbide Market Growth & Trends

The global ultra high purity silicon carbide market size is expected to reach USD 79.0 million by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.8% from 2020 to 2027. The rising penetration of electric vehicles and the growth of the renewable energy sector are projected to provide growth opportunities to market vendors.

Power supplies and photovoltaic inverters are among the significant application areas of silicon carbide (SiC) semiconductors. Moreover, SiC power electronics are adopted in electric vehicle charging products, wind energy infrastructure, and industrial motor drives. Thus, the demand for electric vehicles is expected to boost the growth of ultra-high purity silicon carbide semiconductors. The growing utilization of renewable sources of energy for power generation around the globe is anticipated to drive the market for SiC power semiconductors.

The development of emerging technologies, such as quantum computing, artificial intelligence, and 5G technology, is also anticipated to provide new opportunities for market vendors. Increasing penetration of these technologies, particularly in the U.S., is likely to remain a key factor contributing to the market growth. Companies in the U.S. have invested large sums in these technologies, thereby positively impacting the development of semiconductors required for artificial intelligence, supercomputers, and data centers. For instance, R&D investments in the U.S. semiconductor industry have increased at a CAGR of 6.6% from 1999 to 2019. In the U.S., R&D investments for 2019 amounted to USD 39.8 billion, which was around 17% of its sales, the highest among all the countries.

The increasing demand for light-emitting diodes (LEDs) is another key factor projected to fuel market growth over the coming years. Ultra-high purity silicon carbide is used to remove the impurities in LEDs. The LED lighting market is anticipated to register a growth rate of 13.4% from 2020 to 2027 owing to the decline in prices, stringent regulations related to lighting technologies, and efforts taken by various governments in the direction of sustainable development.

Companies in South Korea are involved in the development of silicon carbide technology, which is projected to remain a key driving factor in the long term. For instance, POSCO, one of the leading steel manufacturers in the globe, invested 10 years in the development of SiC single-crystal. In this project, POSCO is working on the development of 150-mm and 100-mm SiC substrate technology, which is close to commercialization. Another manufacturer SK Corporation (SKC) is likely to commercialize 150-mm SiC wafers.

Request a free sample copy or view report summary: Ultra High Purity Silicon Carbide Market Report

Ultra High Purity Silicon Carbide Market Report Highlights

• In terms of both revenue and volume, semiconductor was the largest application segment in 2019. The growth of the segment is attributed to rising requirements of the increasing middle-class population, and thus indirect demand for electronics
• By application, LEDs are projected to expand at the fastest CAGR of 15.6% in terms of revenue from 2020 to 2027. Increasing awareness regarding global warming has created a positive impact on the demand for LEDs due to their energy efficiency
• The COVID-19 pandemic has created a severe impact on the end-use industries of ultra-high purity silicon carbide (UHPSiC). In terms of volume, demand for UHPSiC is projected to decline by nearly 10% in 2020 from 2019
• Asia Pacific was the largest regional market and accounted for a volume share of 48.0% in 2019. High volume production of electronics and LEDs in China, South Korea, and Taiwan is a key growth factor for the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ultra-high-purity-silicon-carbide-market

Ultra High Purity Silicon Carbide Market Segmentation

Grand View Research has segmented the global ultra high purity silicon carbide market on the basis of application and region:

Ultra High Purity Silicon Carbide Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• Semiconductors
• LEDs
• Others

Ultra High Purity Silicon Carbide Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • Japan
  • India
• Central and South America
  • Brazil
• Middle East & Africa

List of Key Players of Ultra High Purity Silicon Carbide Market

• Washington Mills
• CoorsTek Inc.
• JJISCO Inc.
• Pacific Rundum Co., Ltd.
• American Elements
• LG Innotek

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Retail Vending Machine Market to Expand with Significant CAGR During 2022 – 2030: Grand View Research Inc.

 Retail Vending Machine Market Growth & Trends

The global retail vending machine market size is expected to reach USD 129.40 billion by 2030, registering a CAGR of 10.7% over the forecast period, according to a new report by Grand View Research, Inc. The industry growth can also be attributed to the ability of these machines to deliver goods quickly, making it an extremely convenient option for consumers. Vending machine sales appear to be a potential means of food and beverage distribution, as these machines can sell various consumables, such as cigarettes and lottery tickets, in addition to snacks and beverages. As a result, vending machine operators can create high revenue by strategically installing them in corporate buildings, schools, malls, train stations, and airports, among other locations.

In recent years, IoT technology has provided vending machine operators with the opportunity to improve their businesses by tracking products and assessing what is popular in machines. By tracking stocks through connected devices, vending machine operators can be instantly alerted about low stock levels in their vending machines, which may ultimately reduce expenses and improve customer service. According to Sigfox, the noticeable use of IoT in the vending industry is in plug-and-play smart button devices that attach to machines, enabling individuals to contact facility management instantly. By payment mode, cashless payment technology is expected to witness tremendous growth as it goes hand in hand with payment security.

Although data breaches & scams have impeded the convenience of using a debit/credit card, vending machine operators are working with certain financial institutions to implement the strictest security measures to protect both customers and operators. Operators are adopting various strategies to maximize profit by being at the right location with the right products, sourcing products in bulk, investing in intelligent vending machines to gain consumer insights, and other ways. For instance, hot food and sandwich vending machines may do well in business environments, universities, and schools, while, in most public locations, hot drinks like coffee, tea, and hot chocolate have high demand. Industry players face intense competition from each other, as some of them operate at several locations and have large customer bases. The presence of many small-scale players is also leading to increased competition.

Request a free sample copy or view the report summary: Retail Vending Machine Market Report

Retail Vending Machine Market Report Highlights

• North America accounted for the highest market share in 2021. This region is projected to register a significant CAGR over the forecast period
• The rapid rise of self-service technology in this region has created new business avenues for vending machines. Thus, several operators are focusing on launching their businesses in strategic locations across the region
• The cashless payment segment is estimated to register the fastest CAGR from 2022 to 2030 as this payment method offers convenience and logistical solutions
• Moreover, handling cash in vending machines is a costly process for operators, in terms of time spent collecting and counting money and losses incurred through vandalism and theft
• The office segment is likely to remain at the forefront throughout the forecast period. Vending machines are installed in workplaces to offer employees a convenient, affordable, and quick option for buying food

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vending-machine-market-analysis

Retail Vending Machine Market Segmentation

Grand View Research has segmented the global retail vending machine market based on type, payment mode, application, and region:

Retail Vending Machine Type Outlook (Revenue, USD Million, 2017 - 2030)

• Food
• Beverage
• Games/Amusement
• Tobacco
• Candy & Confectionery
• Beauty & Personal Care
• Ticket
• Others (Ice-cream Vending Machines, Pharmacy, Vending Machine, etc.)

Retail Vending Machine Payment Mode Outlook (Revenue, USD Million, 2017 - 2030)

• Cash
• Cashless

Retail Vending Machine Application Outlook (Revenue, USD Million, 2017 - 2030)

• Commercial Places
• Offices
• Public Places
• Others

Retail Vending Machine Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players in the Retail Vending Machine Market

• Azkoyen Group
• Cantaloupe Systems
• Westomatic Vending Services Limited
• Royal Vendors, Inc.
• Glory Ltd.
• Sanden Holding Corp.
• Seaga Manufacturing Inc.
• Orasesta S.p.A
• Sellmat s.r.l.
• Fuji Electric Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Small Molecule Innovator CDMO Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 Small Molecule Innovator CDMO Market Growth & Trends

The global small molecule innovator CDMO market size is expected to reach USD 74.9 billion by 2030, expanding at 6.21% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. There is a growing interest among pharmaceutical companies in outsourcing to support core competencies such as sales, marketing, and others, due to associated cost savings. Furthermore, outsourcing enables companies to further progress core competencies such as drug development and manufacturing activities. Hence, expansions by small molecule CDMOs in recent years promise major support for the market growth in the upcoming years.

Small molecules continue to play an important role in the development of new treatments globally. Specialty medicines are increasingly driving global pharmaceutical manufacturing growth, particularly in developed markets with small molecule application accounting for over half of specialty sales. The application of small molecules are becoming increasingly complex.

Small Molecule Innovator CDMO Market Report Scope

Report Attribute	Details
Market Size value in 2023	USD 48.6 billion
Revenue forecast in 2030	USD 74.9 billion
Growth Rate	CAGR of 6.4% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

The majority of solutions in the regulatory approval pipeline are made up of poorly soluble compounds that would require enabling technology to progress to clinical trials and beyond. As therapy targets and focus areas become more specific, creating target product profiles has become increasingly difficult. Failure to achieve appropriate bioavailability is an additional stumbling block in the development of many new chemical entities. These factors are expected to support the overall market growth.

The geriatric population is expected to witness a surge in the coming years. For instance, the WHO estimates that there will be more than 2 billion people aged 60 and over by 2050. This would create a lot of opportunities for the development of new small-molecule drugs, which is expected to support the market growth in the post-pandemic period.

Request a free sample copy or view report summary: Small Molecule Innovator CDMO Market Report

Small Molecule Innovator CDMO Market Report Highlights

• The small molecule API segment is anticipated to register the fastest CAGR of 6.7% over the forecast period. This growth can primarily be attributed to the high approval rate of NME small molecules by regulatory agencies
• The clinical stage segment dominated the market with 55.1% of the revenue share in 2022. CDMOs offer specialized expertise, time-saving, and cost-efficiency during clinical procedures. This is expected to augment the segmental growth over the forecast period
• Based on customer type, the pharmaceutical companies segment held the largest share of 93.9% in 2022. The growing focus on pharmaceutical companies to focus on core competencies, such as sales and adoption of expansion strategies by CDMOs for manufacturing small molecule drugs, are promoting the segment’s market growth
• The oncology segment dominated the market with 41.8% of the revenue share in 2022, and it is anticipated to register the fastest CAGR of over 7.0% over the forecast period. A significant number of oncology drugs in the regulatory approval pipeline is one of the major factors supporting the segment’s growth
• Asia Pacific is anticipated to register the fastest CAGR of 7.2% over the forecast period. Due to significantly cheaper manufacturing costs than in North America & Europe and favorable regulations guiding innovation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-small-molecule-innovator-cdmo-market

Small Molecule Innovator CDMO Market Segmentation

Grand View Research has segmented the global small molecule innovator CDMO market based on product, stage type, customer type, therapeutic area, and region:

Small Molecule Innovator CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

• Small Molecule API
• Small Molecule Drug Product
  • Oral solid dose
  • Semi-Solid Dose
  • Liquid Dose
  • Others

Small Molecule Innovator CDMO Stage Type Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical
• Clinical
  • Phase I
    • Small
    • Medium
    • Large
  • Phase II
    • Small
    • Medium
    • Large
  • Phase III
    • Small
    • Medium
    • Large
  • Commercial

Small Molecule Innovator CDMO Customer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical
  • Small
  • Medium
  • Large
• Biotechnology

Small Molecule Innovator CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular disease
• Oncology
• Respiratory disorders
• Neurology
• Metabolic disorders
• Infectious disease
• Others

Small Molecule Innovator CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Small Molecule Innovator CDMO Market

• Piramal Pharma Solutions
• CordenPharma International
• Wuxi AppTec
• Cambrex Corporation
• Recipharm AB
• Pantheon (Thermo Fisher Scientific)
• Lonza
• Catalent Inc.
• Siegfried Holding AG
• Boehringer Ingelheim
• Labcorp Drug Development

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.